UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis

BMC musculoskeletal disorders, 2009-05, Vol.10 (46), p.46-46, Article 46

2009

Volltextzugriff (PDF)

An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor

Journal of rheumatology, 2008-11, Vol.35 (11), p.2119

2008

Volltextzugriff (PDF)

Synthesis and in Vivo Antitumor Evaluation of 2-Methoxyestradiol 3-Phosphate, 17-Phosphate, and 3,17-Diphosphate

Journal of medicinal chemistry, 2007-12, Vol.50 (26), p.6700-6705

2007

Volltextzugriff (PDF)

ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action

Molecular cancer therapeutics, 2011-01, Vol.10 (1), p.126-137

2011

Volltextzugriff (PDF)

Metastatin : A hyaluronan-binding complex from cartilage that inhibits tumor growth

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (3), p.1022-1028

2001

Volltextzugriff (PDF)

Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity

Blood, 2004-05, Vol.103 (9), p.3374-3380

2004

Volltextzugriff (PDF)

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development

Vaccine, 2000-12, Vol.19 (9), p.1294-1303

2000

Volltextzugriff (PDF)

Synergistic activity of recombinant human endostatin in combination with adriamycin: Analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model

Clinical cancer research, 2003-10, Vol.9 (12), p.4619-4626

2003

Volltextzugriff (PDF)

Generation of a Specific Immunological Response to FGF-2 Does Not Affect Wound Healing or Reproduction

Immunopharmacology and immunotoxicology, 2004-01, Vol.26 (1), p.29-41

2004

Volltextzugriff (PDF)

Anti-angiogenic vaccines as a treatment modality for cancer

Current opinion in investigational drugs (London, England : 2000), 2004-12, Vol.5 (12), p.1243

2004

Volltextzugriff (PDF)

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin

The Journal of biological chemistry, 2001-07, Vol.276 (27), p.25190-25196

2001

Volltextzugriff (PDF)

Synergistic Activity of Recombinant Human Endostatin in Combination with Adriamycin

Clinical cancer research, 2003-10, Vol.9 (12), p.4619

2003

Volltextzugriff (PDF)

Endostatin Binds Tropomyosin

The Journal of biological chemistry, 2001-07, Vol.276 (27), p.25190-25196

2001

Volltextzugriff (PDF)

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Blood, 2015-12, Vol.126 (23), p.3498-3498

2015

Volltextzugriff (PDF)

A randomized trial of adding a plano lens to atropine for amblyopia

Journal of AAPOS, 2015-02, Vol.19 (1), p.42-48

2015

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis

An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor

Synthesis and in Vivo Antitumor Evaluation of 2-Methoxyestradiol 3-Phosphate, 17-Phosphate, and 3,17-Diphosphate

ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action

Metastatin : A hyaluronan-binding complex from cartilage that inhibits tumor growth

Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development

Synergistic activity of recombinant human endostatin in combination with adriamycin: Analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model

Generation of a Specific Immunological Response to FGF-2 Does Not Affect Wound Healing or Reproduction

Anti-angiogenic vaccines as a treatment modality for cancer

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin

Synergistic Activity of Recombinant Human Endostatin in Combination with Adriamycin

Endostatin Binds Tropomyosin

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

A randomized trial of adding a plano lens to atropine for amblyopia

Suchergebnisse filtern